hormone

(redirected from luteinizing hormone-releasing hormone)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to luteinizing hormone-releasing hormone: luteinizing hormone-releasing hormone agonist
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for hormone

References in periodicals archive ?
Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues.
Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate.
Testosterone breakthrough during luteinizing hormone-releasing hormone agonist therapy impacts biochemical disease progression: Fact or myth?
Although age at puberty varies widely between and among mammalian species, the main event that signals puberty onset is basically similar, in that it relies on the increased pulsatile secretory activity of a hypothalamic neuropeptide, luteinizing hormone-releasing hormone (LHRH).
The discovery of luteinizing hormone-releasing hormone (LHRH) made available a novel approach to medical castration through suppression of the hypothalamic-pituitary-gonadal axis without the thromboembolic effects of estrogens.[sup.7] Medical ADT is often favoured over orchiectomy because of the potential for intermittent androgen deprivation, lack of procedural complications and possible psychological benefits.
The companion diagnostic will be for the immunohistochemical determination of luteinizing hormone-releasing hormone (LHRH) receptor expression, for the company's doxorubicin LHRH targeted conjugate compound, AEZS-108.
The panel recommended either bilateral orchiectomy or injections with luteinizing hormone-releasing hormone (LHRH) as initial androgen-deprivation treatments.
-- Estradiol pre vents bone loss in prostate cancer patients taking luteinizing hormone-releasing hormone analogues, Dr.
Ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, was in late stage trials for the treatment of benign prostatic hypertrophy.
Treatment with a luteinizing hormone-releasing hormone agonist or with combined androgen blockade would add 7.5 years.
Long-acting luteinizing hormone-releasing hormone (LHRH) agonists, such as goserelin, have been used for locally advanced and metastatic prostate cancer for many years and are the main forms of androgen deprivation therapy (ADT).
Full browser ?